Waters Corporation Appoints Heather Knight to Board of Directors

Rhea-AI Summary

Waters (NYSE:WAT) has appointed Heather Knight to its Board of Directors, effective August 14, 2024. Knight, currently serving as Executive Vice President and Group President, Medical Products and Therapies at Baxter International, brings nearly three decades of experience in the pharmaceutical and medical device industries. Her appointment is expected to enhance the board's oversight of strategy and shareholder value.

Dr. Flemming Ornskov, Chair of the Board, praised Knight's proven track record in driving growth and innovation. Dr. Udit Batra, President and CEO of Waters , highlighted Knight's commitment to operational excellence and her global experience in commercial execution and portfolio innovation as complementary to the board's existing skills.

Positive

• Appointment of an experienced industry leader to the Board of Directors
• Addition of diverse skills and backgrounds to enhance board oversight
• Potential for improved strategy execution and innovation

Negative

• None.

MILFORD, Mass., Aug. 14, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced the appointment of Heather Knight to its Board of Directors effective August 14, 2024. Ms. Knight currently serves as Executive Vice President and Group President, Medical Products and Therapies at Baxter International.

Heather is an accomplished leader who brings decades of experience across the pharma and medical device industries.

"Heather is an accomplished leader who brings decades of experience across the pharmaceutical and medical device industries, with a proven track record for driving growth and innovation," said Dr. Flemming Ornskov, Chair of the Board. "Her experience enriches the diverse skills and backgrounds of our Board members, which is instrumental in our oversight of the strategy and in enhancing shareholder value."

"We are thrilled to welcome Heather to our Board of Directors," said Dr. Udit Batra, President and CEO, Waters Corporation. "Her commitment to operational excellence coupled with her global experience driving commercial execution and portfolio innovation across the MedTech industry will be complementary to our Board. I look forward to collaborating with her as we advance our growth strategy."

"It's an honor to join the Waters Board of Directors at such an exciting time," commented Heather Knight, Executive Vice President and Group President of Medical Products and Therapies at Baxter International. "I've long admired the company and look forward to contributing to its success."

Ms. Knight currently serves as the Executive Vice President and Group President of Medical Products and Therapies at Baxter International. She brings nearly three decades of global business and commercial leadership experience in the pharmaceutical and medical device industries, and a proven track record of driving strong execution, business transformation, and portfolio innovation. She holds a B.S. in Biology from the University of Buffalo.

About Waters Corporation (www.waters.com)

Waters Corporation (NYSE:WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences for more than 65 years. With approximately 7,500 employees worldwide, Waters operates directly in 35 countries, including 15 manufacturing facilities, and with products available in more than 100 countries.

Contact:
Kevin Kempskie
Senior Director Public Relations
Waters Corporation
pr@waters.com
+1.508.478.2000

View original content to download multimedia:https://www.prnewswire.com/news-releases/waters-corporation-appoints-heather-knight-to-board-of-directors-302222613.html

SOURCE Waters Corporation

FAQ

Who is Heather Knight, the new board member of Waters (NYSE:WAT)?

Heather Knight is the Executive Vice President and Group President of Medical Products and Therapies at Baxter International. She brings nearly three decades of global business and commercial leadership experience in the pharmaceutical and medical device industries.

When does Heather Knight's appointment to Waters 's (NYSE:WAT) Board of Directors take effect?

Heather Knight's appointment to Waters 's Board of Directors takes effect on August 14, 2024.

What experience does Heather Knight bring to Waters 's (NYSE:WAT) Board?

Heather Knight brings nearly three decades of experience in the pharmaceutical and medical device industries, with a proven track record in driving growth, innovation, operational excellence, and portfolio innovation across the MedTech industry.

How might Heather Knight's appointment impact Waters (NYSE:WAT)?

Knight's appointment is expected to enhance the board's oversight of strategy, potentially improve execution of growth strategies, and contribute to increasing shareholder value through her extensive industry experience and leadership skills.